Press Releases
Particle Sciences partners with Encube Ethicals to Develop Novel Vaginal Rings
Contract development and manufacturing organization (CDMO), Particle Sciences, a Lubrizol LifeSciences company, has announced its partnership with leading Indian contract manufacturing organization (CMO), Encube Ethicals. Under the partnership the two companies will develop innovative intravaginal rings...
Press Releases
Neovasc Receives Approval to Proceed with Phase 2 of TIARA-II Study from Clinical Regulators in Germany and the UK
Neovasc Inc. ,a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina. Announced that it has completed the Phase...
Press Releases
Horizon Discovery and Rutgers University Form Exclusive Partnership to Develop Next Generation Novel Gene Editing Technology
Horizon Discovery Group plc, a global leader in gene editing and gene modulation technologies, announces that it has entered into an exclusive strategic partnership with Rutgers, The State University of New Jersey , to develop and commercialise a novel...
Press Releases
Manufacturing Consultancy up 150% as Life Sciences prepare for a digital future
Zenith Technologies, a world leader in delivering manufacturing software solutions to the life sciences industry, has seen a 150% rise in demand for its consultancy arm services. Zenith’s Consultancy team offers guidance and support to businesses...
Press Releases
ChargePoint Technology expands smart monitoring technology into North America
Powder containment and sterile transfer solutions provider, ChargePoint Technology has achieved HazLoc (Hazardous Area) certification for VERIFI to further support customers in North America. The HazLoc certification has been granted by the Canadian Standards Association (CSA)...
Press Releases
CRISPR Therapeutics and ProBioGen Sign Collaboration and License Agreement to Develop Novel In Vivo Delivery Technologies
CRISPR Therapeutics , a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, and ProBioGen. A premier German service and technology provider, announced a multi-year research collaboration focused on the development of novel in...
Press Releases
Samsung Bioepis secures FDA approval for cancer drug Ontruzant
The US FDA has granted approval for Samsung Bioepis to use Ontruzant (trastuzumab-dttb) to treat a range of cancers. Ontruzant, which will be marketed in the US by Merck, is a biosimilar to Roche’s Herceptin. It...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















